CPT code 21603 denotes excision of a chest wall tumor involving the ribs with reconstruction of resulting defects, including removal of suspicious mediastinal lymph nodes within the operative field. This complex oncologic and reconstructive procedure is clinically significant due to its impact on thoracic integrity, respiratory mechanics, and oncologic control when tumors invade bony chest structures. Nationally, proper coding guides surgical reporting, facility billing, and utilization monitoring for high-acuity thoracic oncology care.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical procedure and typical sites of service, followed by benchmarking and reimbursement context where available. The publication highlights common modifiers used with this service, payer coverage patterns, and coding considerations relevant to hospitals and surgical providers.

This summary equips clinicians, billing professionals, and policy analysts with a clear understanding of what CPT code 21603 represents, why accurate reporting matters for outcome tracking and resource planning, and where to look for additional policy and reimbursement details. Data not available in the input is noted where specific payer rates, associated taxonomies, ICD-10 mappings, and related codes would otherwise be expected.